Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Long-term Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate Fixed-Dose Combination

This study has been completed.
Information provided by (Responsible Party):
AstraZeneca Identifier:
First received: October 26, 2011
Last updated: June 9, 2016
Last verified: June 2016